Literature DB >> 15212768

Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System.

Catherine Kim1, Gloria L Beckles.   

Abstract

BACKGROUND: Cardiovascular disease (CVD) risk-reduction practices are suboptimal in populations at high risk for CVD, and this problem may be worse in women than in men.
METHODS: In 2003, CVD risk-reduction practices were compared between men and women after stratification by CVD risk status (high, intermediate, low) in a cross-sectional analysis of the 1999 Behavioral Risk Factor Surveillance System (BRFSS), a random-digit telephone survey of state population-based samples of the civilian non-institutionalized population of adults. This analysis included persons aged >40 years who answered questions regarding lipid and blood pressure screening, recommendations for lifestyle modification, that is, exercise and reduced fat intake, and aspirin use. Risk status was defined according to Adult Treatment Panel III definitions.
RESULTS: In the 97,387 adults included in this analysis, high CVD risk was associated with lipid and blood pressure screening, lifestyle modification, and aspirin use in both men and women compared to intermediate-risk and low-risk (p <0.001). Among high-risk adults, men and women reported similar frequency of blood pressure and cholesterol measurement and physician advice on lifestyle modification; among intermediate- and low-risk adults, women reported slightly more frequent screening and lifestyle modification than men (p <0.001). In all CVD risk categories, women reported significantly less aspirin use than in men (p <0.001).
CONCLUSIONS: Among people at high risk for CVD, women report lifestyle modification more often than men, while men report use of aspirin more often than women. These findings may assist with targeting interventions to reduce CVD risk to the unique needs of men and women.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15212768     DOI: 10.1016/j.amepre.2004.03.008

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  22 in total

1.  Combining aspirin with antithrombotic agents.

Authors:  Joseph J Y Sung
Journal:  BMJ       Date:  2006-10-07

2.  Confirmation of reported aspirin use in community studies: utility of serum thromboxane B2 measurement.

Authors:  Nicole Dodge Zantek; Russell V Luepker; Sue Duval; Karen Miller; Niki Oldenburg; Alan T Hirsch
Journal:  Clin Appl Thromb Hemost       Date:  2013-05-07       Impact factor: 2.389

3.  Knowledge, Attitudes, and Practices on Lifestyle and Cardiovascular Risk Factors Among Metabolic Syndrome Patients in an Urban Tertiary Care Institute in Sri Lanka.

Authors:  Priyanwada Amarasekara; Angela de Silva; Hasinthi Swarnamali; Upul Senarath; Prasad Katulanda
Journal:  Asia Pac J Public Health       Date:  2015-10-28       Impact factor: 1.399

Review 4.  Gastrointestinal effects of aspirin.

Authors:  Carlos Sostres; Angel Lanas
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06-07       Impact factor: 46.802

5.  The Association of Aspirin Use with Age-Related Macular Degeneration Progression in the Age-Related Eye Disease Studies: Age-Related Eye Disease Study 2 Report No. 20.

Authors:  Tiarnan D Keenan; Henry E Wiley; Elvira Agrón; Mary E Aronow; William G Christen; Traci E Clemons; Emily Y Chew
Journal:  Ophthalmology       Date:  2019-06-26       Impact factor: 12.079

6.  Use of antithrombotic agents among U.S. stroke survivors, 2000-2006.

Authors:  Eric M Cheng; Stanley N Cohen; Martin L Lee; Stefanie D Vassar; Alex Y Chen
Journal:  Am J Prev Med       Date:  2010-01       Impact factor: 5.043

Review 7.  Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance.

Authors:  Jeffrey S Borer; Lee S Simon
Journal:  Arthritis Res Ther       Date:  2005-09-15       Impact factor: 5.156

8.  Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies.

Authors:  Dominick J Angiolillo; Catherine Datto; Shane Raines; Neville D Yeomans
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

9.  Knowledge, beliefs, and behaviors about hypertension control among middle-aged Korean Americans with hypertension.

Authors:  Hae-Ra Han; Kim B Kim; Jeonghee Kang; Seonghee Jeong; Eun-Young Kim; Miyong T Kim
Journal:  J Community Health       Date:  2007-10

10.  The prevalence of metabolic syndrome among US women of childbearing age.

Authors:  Rosemarie G Ramos; Kenneth Olden
Journal:  Am J Public Health       Date:  2008-04-29       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.